Balderama, Baby Boy .

HRN: 25-57-59  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/30/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
07/30/2024
08/06/2024
IV
14mg
Q 36 Hours
T/C Neonatal Sepsis
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: